# Cristina Brambilla

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/cristina-brambilla/

## Facts

| Field | Value |
| --- | --- |
| Citations | 6,550 |
| Field | Breast Cancer Treatment Studies |
| h-index | 27 |
| i10-index | 60 |
| Last Known Institution | National Research Council |
| OpenAlex ID | https://openalex.org/A5067094608 |
| ORCID iD | 0000-0002-3201-8315 |
| Works | 138 |

## Researcher papers

- [Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer](https://scholariq.org/papers/combination-chemotherapy-as-an-adjuvant-treatment-in-operable-breast-cancer/)
- [Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-up](https://scholariq.org/papers/adjuvant-cyclophosphamide-methotrexate-and-fluorouracil-in-node-positive-breast/)
- [Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or More](https://scholariq.org/papers/primary-chemotherapy-to-avoid-mastectomy-in-tumors-with-diameters-of-three/)
- [Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.](https://scholariq.org/papers/primary-chemotherapy-in-operable-breast-cancer-eight-year-experience-at-the/)
- [High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma](https://scholariq.org/papers/high-dose-chemotherapy-and-autologous-bone-marrow-transplantation-compared-with/)
- [Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer](https://scholariq.org/papers/ten-year-experience-with-cmf-based-adjuvant-chemotherapy-in-resectable-breast/)
- [Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials](https://scholariq.org/papers/anthracycline-containing-and-taxane-containing-chemotherapy-for-early-stage/)
- [Conservation Surgery After Primary Chemotherapy in Large Carcinomas of the Breast](https://scholariq.org/papers/conservation-surgery-after-primary-chemotherapy-in-large-carcinomas-of-the/)
- [Response and survival in advanced breast cancer after two non-cross-resistant combinations.](https://scholariq.org/papers/response-and-survival-in-advanced-breast-cancer-after-two-non-cross-resistant/)
- [Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer](https://scholariq.org/papers/adriamycin-plus-vincristine-compared-to-and-combined-with-cyclophosphamide/)
- [Incorporating gravity into synergistic control of upper limb movements using phasic synergies with positive and negative weights](https://scholariq.org/papers/incorporating-gravity-into-synergistic-control-of-upper-limb-movements-using/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Muscle activation and electromyography studies](https://scholariq.org/topics/muscle-activation-and-electromyography-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Motor Control and Adaptation](https://scholariq.org/topics/motor-control-and-adaptation/)
- [EEG and Brain-Computer Interfaces](https://scholariq.org/topics/eeg-and-brain-computer-interfaces/)

## Researcher university

- [National Research Council](https://scholariq.org/institutions/national-research-council-3/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.